Steffen Klippel

1.6k total citations
27 papers, 1.2k citations indexed

About

Steffen Klippel is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Steffen Klippel has authored 27 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 14 papers in Molecular Biology and 7 papers in Genetics. Recurrent topics in Steffen Klippel's work include Multiple Myeloma Research and Treatments (14 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers) and Acute Myeloid Leukemia Research (6 papers). Steffen Klippel is often cited by papers focused on Multiple Myeloma Research and Treatments (14 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers) and Acute Myeloid Leukemia Research (6 papers). Steffen Klippel collaborates with scholars based in United States, Germany and Slovakia. Steffen Klippel's co-authors include Paul G. Richardson, Constantine S. Mitsiades, Kenneth C. Anderson, Douglas W. McMillin, Jake Delmore, Heike L. Pahl, Nikhil C. Munshi, Elisabeth Strunck, Joseph Negri and Teru Hideshima and has published in prestigious journals such as Nature Medicine, Nature Genetics and Blood.

In The Last Decade

Steffen Klippel

27 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steffen Klippel United States 15 686 611 363 326 146 27 1.2k
Cong Peng China 20 655 1.0× 578 0.9× 215 0.6× 288 0.9× 157 1.1× 51 1.3k
Monica Pallis United Kingdom 23 674 1.0× 590 1.0× 509 1.4× 168 0.5× 155 1.1× 61 1.3k
Luc Van Rompaey Belgium 16 568 0.8× 493 0.8× 594 1.6× 411 1.3× 285 2.0× 31 1.4k
Annalisa Lonetti Italy 24 824 1.2× 536 0.9× 251 0.7× 280 0.9× 157 1.1× 57 1.5k
Karen Dunn United Kingdom 13 801 1.2× 510 0.8× 180 0.5× 261 0.8× 207 1.4× 29 1.4k
Malgorzata Nieborowska-Skorska United States 15 765 1.1× 678 1.1× 404 1.1× 430 1.3× 160 1.1× 17 1.5k
Boris Kovačic Austria 17 463 0.7× 461 0.8× 692 1.9× 354 1.1× 389 2.7× 25 1.4k
G. Vignir Helgason United Kingdom 19 1.1k 1.6× 976 1.6× 291 0.8× 463 1.4× 134 0.9× 40 1.9k
Livia Manzella Italy 23 878 1.3× 456 0.7× 467 1.3× 345 1.1× 181 1.2× 68 1.8k
Jennifer Callahan United States 11 467 0.7× 330 0.5× 294 0.8× 290 0.9× 99 0.7× 19 1.0k

Countries citing papers authored by Steffen Klippel

Since Specialization
Citations

This map shows the geographic impact of Steffen Klippel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steffen Klippel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steffen Klippel more than expected).

Fields of papers citing papers by Steffen Klippel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steffen Klippel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steffen Klippel. The network helps show where Steffen Klippel may publish in the future.

Co-authorship network of co-authors of Steffen Klippel

This figure shows the co-authorship network connecting the top 25 collaborators of Steffen Klippel. A scholar is included among the top collaborators of Steffen Klippel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steffen Klippel. Steffen Klippel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leiba, Merav, Jana Jakubı́ková, Steffen Klippel, et al.. (2012). Halofuginone inhibits multiple myeloma growth in vitro and in vivo and enhances cytotoxicity of conventional and novel agents. British Journal of Haematology. 157(6). 718–731. 28 indexed citations
2.
Jakubı́ková, Jana, Sophia Adamia, Maria Kost‐Alimova, et al.. (2011). Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications. Blood. 117(17). 4409–4419. 122 indexed citations
3.
Jakubı́ková, Jana, David Cervi, Melissa Ooi, et al.. (2011). Anti-tumor activity and signaling events triggered by the isothiocyanates, sulforaphane and phenethyl isothiocyanate, in multiple myeloma. Haematologica. 96(8). 1170–1179. 63 indexed citations
4.
Donk, Niels W.C.J. van de, Henk M. Lokhorst, Maarten E. Emmelot, et al.. (2011). Proteasome Inhibitors Sensitize Myeloma Cells to T Cell-Mediated Killing. Blood. 118(21). 1838–1838. 2 indexed citations
5.
McMillin, Douglas W., Jake Delmore, Joseph Negri, et al.. (2011). Microenvironmental Influence on Pre-Clinical Activity of Polo-Like Kinase Inhibition in Multiple Myeloma: Implications for Clinical Translation. PLoS ONE. 6(7). e20226–e20226. 24 indexed citations
6.
McMillin, Douglas W., Jake Delmore, Ellen Weisberg, et al.. (2010). Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity. Nature Medicine. 16(4). 483–489. 236 indexed citations
7.
Kastritis, Efstathios, Jana Jakubı́ková, Jake Delmore, et al.. (2010). Preclinical Studies of Salinomycin In Multiple Myeloma (MM) Models: Targeting of Side Population (SP) Cells In the Context of Tumor – Microenvironment Interactions.. Blood. 116(21). 1574–1574. 1 indexed citations
8.
Mitsiades, Constantine S., Teru Hideshima, Dharminder Chauhan, et al.. (2009). Emerging Treatments for Multiple Myeloma: Beyond Immunomodulatory Drugs and Bortezomib. Seminars in Hematology. 46(2). 166–175. 46 indexed citations
9.
Negri, Joseph, Douglas W. McMillin, Jake Delmore, et al.. (2009). In vitro anti‐myeloma activity of the Aurora kinase inhibitor VE‐465. British Journal of Haematology. 147(5). 672–676. 26 indexed citations
10.
Ooi, Melissa, Robert O’Connor, Jana Jakubı́ková, et al.. (2009). The Interaction of Bortezomib with P-Gp, MRP-1 and BCRP Drug Transporters: Implications for Therapeutic Applications of Bortezomib in Advanced Multiple Myeloma and Other Neoplasias.. Blood. 114(22). 1729–1729. 1 indexed citations
11.
12.
13.
Mitsiades, Constantine S., Douglas W. McMillin, Steffen Klippel, et al.. (2007). The Role of the Bone Marrow Microenvironment in the Pathophysiology of Myeloma and Its Significance in the Development of More Effective Therapies. Hematology/Oncology Clinics of North America. 21(6). 1007–1034. 94 indexed citations
14.
Steidl, Ulrich, Frank Rosenbauer, Roel G.W. Verhaak, et al.. (2006). Essential role of Jun family transcription factors in PU.1 knockdown–induced leukemic stem cells. Nature Genetics. 38(11). 1269–1277. 132 indexed citations
15.
Steidl, Ulrich, Frank Rosenbauer, Roel G.W. Verhaak, et al.. (2005). Essential Role of Jun Family Transcription Factors in PU.1-Induced Leukemic Stem Cell Transformation.. Blood. 106(11). 463–463. 3 indexed citations
16.
Klippel, Steffen & Heike L. Pahl. (2004). Molecular markers for the diagnosis of Philadelphia chromosome negative myeloproliferative disorders. Pathologie Biologie. 52(5). 267–274. 8 indexed citations
17.
Grießhammer, Martin, Steffen Klippel, Elisabeth Strunck, et al.. (2004). PRV-1 mRNA expression discriminates two types of essential thrombocythemia. Annals of Hematology. 83(6). 364–370. 47 indexed citations
18.
Klippel, Steffen. (2003). Quantification of PRV-1 mRNA distinguishes polycythemia vera from secondary erythrocytosis. Blood. 102(10). 3569–3574. 63 indexed citations
19.
Klippel, Steffen, Elisabeth Strunck, Christian E. Busse, Dirk Behringer, & Heike L. Pahl. (2002). Biochemical characterization of PRV-1, a novel hematopoietic cell surface receptor, which is overexpressed in polycythemia rubra vera. Blood. 100(7). 2441–2448. 47 indexed citations
20.
Temerinac, S., Steffen Klippel, Elisabeth Strunck, et al.. (2000). Cloning of PRV-1, a novel member of the uPAR receptor superfamily, which is overexpressed in polycythemia rubra vera. Blood. 95(8). 2569–2576. 164 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cong Peng Breakdown of academic impact, for papers by Monica Pallis Breakdown of academic impact, for papers by Luc Van Rompaey Breakdown of academic impact, for papers by Annalisa Lonetti Breakdown of academic impact, for papers by Karen Dunn Breakdown of academic impact, for papers by Malgorzata Nieborowska-Skorska Breakdown of academic impact, for papers by Boris Kovačic Breakdown of academic impact, for papers by G. Vignir Helgason Breakdown of academic impact, for papers by Livia Manzella Breakdown of academic impact, for papers by Jennifer Callahan
Rankless by CCL
2026